Xenon Pharmaceuticals Inc. (XENE)

USD 39.35

(-4.68%)

Annual Balance Sheets

(In USD)
Breakdown 2023 2022 2021 2020 2019 2018
Total Assets 964.79 Million 754.14 Million 572 Million 189.18 Million 147.69 Million 122.42 Million
Total Current Assets 644.96 Million 600.29 Million 559.02 Million 181.78 Million 144.86 Million 121.43 Million
Cash And Short Term Investments 638.08 Million 592.08 Million 551.77 Million 176.99 Million 141.35 Million 119.3 Million
Cash and Cash Equivalents 148.64 Million 57.24 Million 175.68 Million 45 Million 24.75 Million 67.75 Million
Short Term Investments 489.43 Million 534.84 Million 376.08 Million 131.98 Million 116.6 Million 51.55 Million
Net Receivables 874 Thousand 986 Thousand 2.76 Million 1.82 Million 813 Thousand 256 Thousand
Inventory 1.00 -986 Thousand -2.76 Million -1.82 Million - -
Other Current Assets 6 Million 8.21 Million 7.24 Million 4.78 Million 2.69 Million 1.87 Million
Total Non-Current Assets 319.83 Million 153.84 Million 12.98 Million 7.4 Million 2.83 Million 991 Thousand
Net PPE 18.84 Million 16.9 Million 12.52 Million 6.88 Million 2.59 Million 991 Thousand
Good Will And Intangible Assets - - - - - -
Good Will - - - - - -
Intangible Assets - - - - - -
Long-Term Investments 292.79 Million 128.68 Million - - - -
Tax Assets 802 Thousand 509 Thousand 465 Thousand 523 Thousand 238 Thousand 105 Thousand
Other Non Current Assets 7.39 Million 7.75 Million - - - -105 Thousand
Other Assets - - - - - -
Total Liabilities 36.87 Million 32.64 Million 21.97 Million 17.83 Million 55.72 Million 19.13 Million
Total Current Liabilities 27.27 Million 22.7 Million 14.32 Million 14.78 Million 43.37 Million 4.11 Million
Account Payables 8.59 Million 8.49 Million 3.82 Million 3.04 Million 2.47 Million 665 Thousand
Tax Payables - - - - - -
Short Term Debt 1.29 Million 488 Thousand 605 Thousand 265 Thousand 4.81 Million 15.01 Million
Deferred Revenue - - 9.28 Million 3.64 Million 29.74 Million -15.01 Million
Other Current Liabilities 17.37 Million 13.72 Million 605 Thousand 7.83 Million 6.34 Million 3.45 Million
Total Non Current Liabilities 9.6 Million 9.94 Million 7.65 Million 3.05 Million 12.34 Million 15.01 Million
Long-Term Debt 9.6 Million 9.94 Million 7.65 Million 3.05 Million 11.63 Million 15.01 Million
Deferred Revenue Non Current - - - - 709 Thousand -
Deferred Tax Liabilities Non Current - - - - - -
Other Non Current Liabilities - -509 Thousand - - -10.88 Million -
Other Liabilities - - - - - -
Total Equity 927.92 Million 721.49 Million 550.03 Million 171.35 Million 91.97 Million 103.29 Million
Stock Holders Equity 927.92 Million 721.49 Million 550.03 Million 171.35 Million 91.97 Million 103.29 Million
Common Stock 1.43 Billion 1.06 Billion 783.17 Million 397.74 Million 294.24 Million 265.92 Million
Retained Earnings -665.14 Million -482.74 Million -357.37 Million -278.49 Million -249.65 Million -207.88 Million
Accumulated other comprehensive income -77 Thousand -3 Million -990 Thousand -990 Thousand -990 Thousand -990 Thousand
Common Stock Equity 927.92 Million 721.49 Million 550.03 Million 171.35 Million 91.97 Million 103.29 Million
Capital Lease Obligation 9.6 Million 10.43 Million 8.25 Million 3.31 Million 911 Thousand -
Total Investments 782.23 Million 663.52 Million 376.08 Million 131.98 Million 116.6 Million 51.55 Million
Total Debt 10.9 Million 10.43 Million 8.25 Million 3.31 Million 16.45 Million 15.01 Million
Net Debt -137.74 Million -46.8 Million -167.43 Million -41.69 Million -8.3 Million -52.74 Million

Balance Sheet Charts